You are here

Treatments

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

Fri, 2022-08-19 20:38 — mike kraft

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound The U.S. Food and Drug Administration (FDA) has ordered Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
Log in or register to post comments

How to assess risk for long term Covid issues--CNN

Fri, 2022-08-19 13:56 — mike kraft

Long Covid risk extends two years after infection. Here's how to assess your risk A new study found an increased risk of certain long Covid-19 symptoms up to two years after an original infection. Sandee LaMotte, CNN CNN

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about How to assess risk for long term Covid issues--CNN
Log in or register to post comments

Ebola: WHO recommends use of two antibody drugs against Ebola

Fri, 2022-08-19 13:10 — mike kraft

WHO recommends use of two antibody drugs against Ebola The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against Ebola, saying the use of such drugs combined with better care had "revolutionised" the treatment of a disease once seen as a near-certain killer. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Ebola: WHO recommends use of two antibody drugs against Ebola
Log in or register to post comments

Pages